-
Novel blindness gene therapy shows promise in first-in-human trial
europeanpharmaceuticalreview
April 21, 2021
The lowest dose of the gene therapy was shown to be safe and somewhat improved vision in the first three patients treated in the trial.
-
VISTA Eye Specialist Going Digital to Raise Awareness on Preventable Blindness
prnasia
April 13, 2020
Amidst the global effort to stem the spread of the COVID-19 virus, including Malaysia adopting its own Movement Control Order (MCO), VISTA Eye Specialist is not holding back their effort in its "War against Blindness" campaign.
-
Wearing Contacts 24/7 Can Bring Infection, Blindness, Doctors Warn
drugs
December 20, 2018
Dangerous infections, blinding ulcers in the eyes: These are just some of the troubles that can come from wearing your contacts for too long.....
-
ProQR drug for rare childhood blindness succeeds in early trial
financialexpress
September 06, 2018
The early trial tested the RNA-based drug, QR-110, in 10 patients with a certain genetic mutation that resulted in an eye disorder called Leber’s congenital amaurosis 10
-
With promising data, ProQR Therapeutics' RNA-based eye drug heads to phase 3
fiercebiotech
September 06, 2018
ProQR’s treatment, QR-110, is designed to repair the genetic defect underlying LCA10 in the RNA, which could potentially stop disease progression or even reverse some of its effects.
-
Pfizer announces extension of Zithromax® Antibiotic Donation Program through 2025 to help eliminate world's leading infectious cause of blindness
worldpharmanews
June 20, 2018
Pfizer Inc. will extend its donation of the antibiotic Zithromax® (azithromycin) to the International Trachoma Initiative through 2025